B-type natriuretic peptide: A universal cardiac biomarker?

Nicholas Teodorovich, Ricardo Krakover, Zvi Vered

Research output: Contribution to journalEditorial


In summary, natriuretic peptide has an, important role in risk stratification in modern cardiology. Its usefulness in the ambulatory setting in patients with advanced CHF was demonstrated by Amir and co-authors [19]. Correctly interpreting the BNP levels in such patients can help the attending physician to provide better care, improve the quality of life and perhaps even prolong life. However, the cost-effectiveness of such an approach should be carefully evaluated.

Original languageEnglish
Pages (from-to)152-153
Number of pages2
JournalIsrael Medical Association Journal
Issue number2
StatePublished - Feb 2008


  • B-type natriuretic peptide
  • Biomarkers
  • Chronic heart failure
  • Ventricular dysfunction


Dive into the research topics of 'B-type natriuretic peptide: A universal cardiac biomarker?'. Together they form a unique fingerprint.

Cite this